カテゴリー： GlobalInfoResearch, 世界

病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Disease Risk and Health Test Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102763）・商品コード：GIR9102763
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：136
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、病気リスクおよび健康診断の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。病気リスクおよび健康診断の世界市場概観、企業動向、企業別病気リスクおよび健康診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・病気リスクおよび健康診断の市場概観
・病気リスクおよび健康診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・病気リスクおよび健康診断の企業別販売動向、市場シェア、市場集中度、競争動向
・病気リスクおよび健康診断の世界市場規模
・病気リスクおよび健康診断の北米市場分析（アメリカ、カナダ、メキシコ等）
・病気リスクおよび健康診断のアメリカ市場規模推移
・病気リスクおよび健康診断のカナダ市場規模推移
・病気リスクおよび健康診断のメキシコ市場規模推移
・病気リスクおよび健康診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・病気リスクおよび健康診断のドイツ市場規模推移
・病気リスクおよび健康診断のイギリス市場規模推移
・病気リスクおよび健康診断のロシア市場規模推移
・病気リスクおよび健康診断のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・病気リスクおよび健康診断の日本市場規模推移
・病気リスクおよび健康診断の中国市場規模推移
・病気リスクおよび健康診断の韓国市場規模推移
・病気リスクおよび健康診断のインド市場規模推移
・病気リスクおよび健康診断の東南アジア市場規模推移
・病気リスクおよび健康診断の南米市場分析（ブラジル、アルゼンチン等）
・病気リスクおよび健康診断の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・病気リスクおよび健康診断の種類別分析/販売量、売上、市場シェア（セリアック病、パーキンソン病、アルツハイマー病、その他）
・病気リスクおよび健康診断の用途別分析/市場規模（オンライン、オフライン）
・病気リスクおよび健康診断の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・病気リスクおよび健康診断の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.

Scope of the Report:
The global Disease Risk and Health Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Disease Risk and Health Test.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Disease Risk and Health Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Disease Risk and Health Test market by product type and applications/end industries.

Market Segment by Companies, this report covers
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other

Market Segment by Applications, can be divided into
Online
Offline

【レポートの目次】

Table of Contents

1 Disease Risk and Health Test Market Overview
1.1 Product Overview and Scope of Disease Risk and Health Test
1.2 Classification of Disease Risk and Health Test by Types
1.2.1 Global Disease Risk and Health Test Revenue Comparison by Types (2019-2024)
1.2.2 Global Disease Risk and Health Test Revenue Market Share by Types in 2018
1.2.3 Celiac Disease
1.2.4 Parkinson Disease
1.2.5 Alzheimer Disease
1.2.6 Other
1.3 Global Disease Risk and Health Test Market by Application
1.3.1 Global Disease Risk and Health Test Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Online
1.3.3 Offline
1.4 Global Disease Risk and Health Test Market by Regions
1.4.1 Global Disease Risk and Health Test Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Disease Risk and Health Test Status and Prospect (2014-2024)
1.5 Global Market Size of Disease Risk and Health Test (2014-2024)
2 Manufacturers Profiles
2.1 23andMe
2.1.1 Business Overview
2.1.2 Disease Risk and Health Test Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 23andMe Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.2 MyHeritage
2.2.1 Business Overview
2.2.2 Disease Risk and Health Test Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 MyHeritage Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.3 LabCorp
2.3.1 Business Overview
2.3.2 Disease Risk and Health Test Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 LabCorp Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.4 Myriad Genetics
2.4.1 Business Overview
2.4.2 Disease Risk and Health Test Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Myriad Genetics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.5 Ancestry.com
2.5.1 Business Overview
2.5.2 Disease Risk and Health Test Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ancestry.com Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.6 Quest Diagnostics
2.6.1 Business Overview
2.6.2 Disease Risk and Health Test Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Quest Diagnostics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.7 Gene By Gene
2.7.1 Business Overview
2.7.2 Disease Risk and Health Test Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Gene By Gene Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.8 DNA Diagnostics Center
2.8.1 Business Overview
2.8.2 Disease Risk and Health Test Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DNA Diagnostics Center Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.9 Invitae
2.9.1 Business Overview
2.9.2 Disease Risk and Health Test Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Invitae Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.10 IntelliGenetics
2.10.1 Business Overview
2.10.2 Disease Risk and Health Test Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 IntelliGenetics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.11 Ambry Genetics
2.11.1 Business Overview
2.11.2 Disease Risk and Health Test Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ambry Genetics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.12 Living DNA
2.12.1 Business Overview
2.12.2 Disease Risk and Health Test Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Living DNA Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.13 EasyDNA
2.13.1 Business Overview
2.13.2 Disease Risk and Health Test Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 EasyDNA Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.14 Pathway Genomics
2.14.1 Business Overview
2.14.2 Disease Risk and Health Test Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Pathway Genomics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.15 Centrillion Technology
2.15.1 Business Overview
2.15.2 Disease Risk and Health Test Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Centrillion Technology Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.16 Xcode
2.16.1 Business Overview
2.16.2 Disease Risk and Health Test Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Xcode Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.17 Color Genomics
2.17.1 Business Overview
2.17.2 Disease Risk and Health Test Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Color Genomics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.18 Anglia DNA Services
2.18.1 Business Overview
2.18.2 Disease Risk and Health Test Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Anglia DNA Services Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.19 African Ancestry
2.19.1 Business Overview
2.19.2 Disease Risk and Health Test Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 African Ancestry Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.20 Canadian DNA Services
2.20.1 Business Overview
2.20.2 Disease Risk and Health Test Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Canadian DNA Services Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.21 DNA Family Check
2.21.1 Business Overview
2.2.2 Disease Risk and Health Test Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 DNA Family Check Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.22 Alpha Biolaboratories
2.22.1 Business Overview
2.22.2 Disease Risk and Health Test Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Alpha Biolaboratories Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.23 Test Me DNA
2.23.1 Business Overview
2.23.2 Disease Risk and Health Test Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Test Me DNA Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.24 23 Mofang
2.24.1 Business Overview
2.24.2 Disease Risk and Health Test Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 23 Mofang Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.25 Genetic Health
2.25.1 Business Overview
2.25.2 Disease Risk and Health Test Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Genetic Health Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.26 DNA Services of America
2.26.1 Business Overview
2.26.2 Disease Risk and Health Test Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 DNA Services of America Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.27 Shuwen Health Sciences
2.27.1 Business Overview
2.27.2 Disease Risk and Health Test Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shuwen Health Sciences Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.28 Mapmygenome
2.28.1 Business Overview
2.28.2 Disease Risk and Health Test Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Mapmygenome Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.29 Full Genomes
2.29.1 Business Overview
2.29.2 Disease Risk and Health Test Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Full Genomes Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
3 Global Disease Risk and Health Test Market Competition, by Players
3.1 Global Disease Risk and Health Test Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Disease Risk and Health Test Players Market Share
3.2.2 Top 10 Disease Risk and Health Test Players Market Share
3.3 Market Competition Trend
4 Global Disease Risk and Health Test Market Size by Regions
4.1 Global Disease Risk and Health Test Revenue and Market Share by Regions
4.2 North America Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.3 Europe Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.5 South America Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
5 North America Disease Risk and Health Test Revenue by Countries
5.1 North America Disease Risk and Health Test Revenue by Countries (2014-2019)
5.2 USA Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
5.3 Canada Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
5.4 Mexico Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6 Europe Disease Risk and Health Test Revenue by Countries
6.1 Europe Disease Risk and Health Test Revenue by Countries (2014-2019)
6.2 Germany Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.3 UK Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.4 France Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.5 Russia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.6 Italy Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Disease Risk and Health Test Revenue by Countries
7.1 Asia-Pacific Disease Risk and Health Test Revenue by Countries (2014-2019)
7.2 China Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.3 Japan Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.4 Korea Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.5 India Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
8 South America Disease Risk and Health Test Revenue by Countries
8.1 South America Disease Risk and Health Test Revenue by Countries (2014-2019)
8.2 Brazil Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
8.3 Argentina Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
8.4 Colombia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Disease Risk and Health Test by Countries
9.1 Middle East and Africa Disease Risk and Health Test Revenue by Countries (2014-2019)
9.2 Saudi Arabia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.3 UAE Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.4 Egypt Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.5 Nigeria Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.6 South Africa Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
10 Global Disease Risk and Health Test Market Segment by Type
10.1 Global Disease Risk and Health Test Revenue and Market Share by Type (2014-2019)
10.2 Global Disease Risk and Health Test Market Forecast by Type (2019-2024)
10.3 Celiac Disease Revenue Growth Rate (2014-2024)
10.4 Parkinson Disease Revenue Growth Rate (2014-2024)
10.5 Alzheimer Disease Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Disease Risk and Health Test Market Segment by Application
11.1 Global Disease Risk and Health Test Revenue Market Share by Application (2014-2019)
11.2 Disease Risk and Health Test Market Forecast by Application (2019-2024)
11.3 Online Revenue Growth (2014-2019)
11.4 Offline Revenue Growth (2014-2019)
12 Global Disease Risk and Health Test Market Size Forecast (2019-2024)
12.1 Global Disease Risk and Health Test Market Size Forecast (2019-2024)
12.2 Global Disease Risk and Health Test Market Forecast by Regions (2019-2024)
12.3 North America Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.4 Europe Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.6 South America Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Disease Risk and Health Test Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Disease Risk and Health Test Picture
Table Product Specifications of Disease Risk and Health Test
Table Global Disease Risk and Health Test and Revenue (Million USD) Market Split by Product Type
Figure Global Disease Risk and Health Test Revenue Market Share by Types in 2018
Figure Celiac Disease Picture
Figure Parkinson Disease Picture
Figure Alzheimer Disease Picture
Figure Other Picture
Table Global Disease Risk and Health Test Revenue (Million USD) by Application (2014-2024)
Figure Disease Risk and Health Test Revenue Market Share by Applications in 2018
Figure Online Picture
Figure Offline Picture
Table Global Market Disease Risk and Health Test Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Table 23andMe Basic Information, Manufacturing Base and Competitors
Table 23andMe Disease Risk and Health Test Type and Applications
Table 23andMe Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table MyHeritage Basic Information, Manufacturing Base and Competitors
Table MyHeritage Disease Risk and Health Test Type and Applications
Table MyHeritage Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table LabCorp Basic Information, Manufacturing Base and Competitors
Table LabCorp Disease Risk and Health Test Type and Applications
Table LabCorp Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Disease Risk and Health Test Type and Applications
Table Myriad Genetics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Ancestry.com Basic Information, Manufacturing Base and Competitors
Table Ancestry.com Disease Risk and Health Test Type and Applications
Table Ancestry.com Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Disease Risk and Health Test Type and Applications
Table Quest Diagnostics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Gene By Gene Basic Information, Manufacturing Base and Competitors
Table Gene By Gene Disease Risk and Health Test Type and Applications
Table Gene By Gene Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table DNA Diagnostics Center Basic Information, Manufacturing Base and Competitors
Table DNA Diagnostics Center Disease Risk and Health Test Type and Applications
Table DNA Diagnostics Center Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Invitae Basic Information, Manufacturing Base and Competitors
Table Invitae Disease Risk and Health Test Type and Applications
Table Invitae Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table IntelliGenetics Basic Information, Manufacturing Base and Competitors
Table IntelliGenetics Disease Risk and Health Test Type and Applications
Table IntelliGenetics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table Ambry Genetics Disease Risk and Health Test Type and Applications
Table Ambry Genetics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Living DNA Basic Information, Manufacturing Base and Competitors
Table Living DNA Disease Risk and Health Test Type and Applications
Table Living DNA Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table EasyDNA Basic Information, Manufacturing Base and Competitors
Table EasyDNA Disease Risk and Health Test Type and Applications
Table EasyDNA Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table Pathway Genomics Disease Risk and Health Test Type and Applications
Table Pathway Genomics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Centrillion Technology Basic Information, Manufacturing Base and Competitors
Table Centrillion Technology Disease Risk and Health Test Type and Applications
Table Centrillion Technology Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Xcode Basic Information, Manufacturing Base and Competitors
Table Xcode Disease Risk and Health Test Type and Applications
Table Xcode Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Color Genomics Basic Information, Manufacturing Base and Competitors
Table Color Genomics Disease Risk and Health Test Type and Applications
Table Color Genomics Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Anglia DNA Services Basic Information, Manufacturing Base and Competitors
Table Anglia DNA Services Disease Risk and Health Test Type and Applications
Table Anglia DNA Services Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table African Ancestry Basic Information, Manufacturing Base and Competitors
Table African Ancestry Disease Risk and Health Test Type and Applications
Table African Ancestry Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Canadian DNA Services Basic Information, Manufacturing Base and Competitors
Table Canadian DNA Services Disease Risk and Health Test Type and Applications
Table Canadian DNA Services Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table DNA Family Check Basic Information, Manufacturing Base and Competitors
Table DNA Family Check Disease Risk and Health Test Type and Applications
Table DNA Family Check Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Alpha Biolaboratories Basic Information, Manufacturing Base and Competitors
Table Alpha Biolaboratories Disease Risk and Health Test Type and Applications
Table Alpha Biolaboratories Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Test Me DNA Basic Information, Manufacturing Base and Competitors
Table Test Me DNA Disease Risk and Health Test Type and Applications
Table Test Me DNA Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table 23 Mofang Basic Information, Manufacturing Base and Competitors
Table 23 Mofang Disease Risk and Health Test Type and Applications
Table 23 Mofang Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Genetic Health Basic Information, Manufacturing Base and Competitors
Table Genetic Health Disease Risk and Health Test Type and Applications
Table Genetic Health Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table DNA Services of America Basic Information, Manufacturing Base and Competitors
Table DNA Services of America Disease Risk and Health Test Type and Applications
Table DNA Services of America Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Shuwen Health Sciences Basic Information, Manufacturing Base and Competitors
Table Shuwen Health Sciences Disease Risk and Health Test Type and Applications
Table Shuwen Health Sciences Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Mapmygenome Basic Information, Manufacturing Base and Competitors
Table Mapmygenome Disease Risk and Health Test Type and Applications
Table Mapmygenome Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Full Genomes Basic Information, Manufacturing Base and Competitors
Table Full Genomes Disease Risk and Health Test Type and Applications
Table Full Genomes Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Global Disease Risk and Health Test Revenue (Million USD) by Players (2014-2019)
Table Global Disease Risk and Health Test Revenue Share by Players (2014-2019)
Figure Global Disease Risk and Health Test Revenue Share by Players in 2017
Figure Global Disease Risk and Health Test Revenue Share by Players in 2018
Figure Global Top 5 Players Disease Risk and Health Test Revenue Market Share in 2018
Figure Global Top 10 Players Disease Risk and Health Test Revenue Market Share in 2018
Figure Global Disease Risk and Health Test Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Disease Risk and Health Test Revenue (Million USD) by Regions (2014-2019)
Table Global Disease Risk and Health Test Revenue Market Share by Regions (2014-2019)
Figure Global Disease Risk and Health Test Revenue Market Share by Regions (2014-2019)
Figure Global Disease Risk and Health Test Revenue Market Share by Regions in 2018
Figure North America Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Europe Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure South America Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table North America Disease Risk and Health Test Revenue by Countries (2014-2019)
Table North America Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure North America Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure North America Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure USA Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Canada Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Mexico Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Europe Disease Risk and Health Test Revenue (Million USD) by Countries (2014-2019)
Figure Europe Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Europe Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure Germany Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure UK Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure France Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Russia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Italy Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Disease Risk and Health Test Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure China Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Japan Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Korea Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure India Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table South America Disease Risk and Health Test Revenue by Countries (2014-2019)
Table South America Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure South America Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure South America Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure Brazil Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Argentina Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Colombia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Disease Risk and Health Test Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure Saudi Arabia Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure UAE Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Egypt Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Nigeria Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure South Africa Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Global Disease Risk and Health Test Revenue (Million USD) by Type (2014-2019)
Table Global Disease Risk and Health Test Revenue Share by Type (2014-2019)
Figure Global Disease Risk and Health Test Revenue Share by Type (2014-2019)
Figure Global Disease Risk and Health Test Revenue Share by Type in 2019
Table Global Disease Risk and Health Test Revenue Forecast by Type (2019-2024)
Figure Global Disease Risk and Health Test Market Share Forecast by Type (2019-2024)
Figure Global Celiac Disease Revenue Growth Rate (2014-2019)
Figure Global Parkinson Disease Revenue Growth Rate (2014-2019)
Figure Global Alzheimer Disease Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Disease Risk and Health Test Revenue by Application (2014-2019)
Table Global Disease Risk and Health Test Revenue Share by Application (2014-2019)
Figure Global Disease Risk and Health Test Revenue Share by Application (2014-2019)
Figure Global Disease Risk and Health Test Revenue Share by Application in 2019
Table Global Disease Risk and Health Test Revenue Forecast by Application (2019-2024)
Figure Global Disease Risk and Health Test Market Share Forecast by Application (2019-2024)
Figure Global Online Revenue Growth Rate (2014-2019)
Figure Global Offline Revenue Growth Rate (2014-2019)
Figure Global Disease Risk and Health Test Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Disease Risk and Health Test Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Disease Risk and Health Test Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure Europe Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure South America Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Disease Risk and Health Test Revenue Market Forecast (2019-2024)


【掲載企業】

23andMe、MyHeritage、LabCorp、Myriad Genetics、Ancestry.com、Quest Diagnostics、Gene By Gene、DNA Diagnostics Center、Invitae、IntelliGenetics、Ambry Genetics、Living DNA、EasyDNA、Pathway Genomics、Centrillion Technology、Xcode、Color Genomics、Anglia DNA Services、African Ancestry、Canadian DNA Services、DNA Family Check、Alpha Biolaboratories、Test Me DNA、23 Mofang、Genetic Health、DNA Services of America、Shuwen Health Sciences、Mapmygenome、Full Genomes、

★調査レポート[病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102763)販売に関する免責事項を必ずご確認ください。
★調査レポート[病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 疾病リスクおよび健康遺伝子検査の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102762 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、疾病リスクおよび健康遺伝子検査の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。疾病リスクおよび健康遺伝子検査の世界市場概観、企業動向、企業別疾病リスクおよび健康遺伝子検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・疾病リスクおよび健康遺伝子検査の市場概観 ・疾病リスクおよび健康遺伝子検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・疾病リスクおよび健康遺伝子検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・疾病リスクおよび健康遺伝子検査の世界市場規模 ・疾病リスクおよび健康遺伝子検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・疾病リスクおよび健康遺伝子検査のアメリカ市場規模推移 ・疾病リスクおよび健康遺伝子検査のカナダ市場規模推移 ・疾病リスクおよび健康遺伝子検査のメキシコ市場規模推移 ・疾病リスクおよび健康遺伝子検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The global Disease Risk and Health Genetic Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019...
  • DTC病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102765 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、DTC病気リスクおよび健康診断の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC病気リスクおよび健康診断の世界市場概観、企業動向、企業別DTC病気リスクおよび健康診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・DTC病気リスクおよび健康診断の市場概観 ・DTC病気リスクおよび健康診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・DTC病気リスクおよび健康診断の企業別販売動向、市場シェア、市場集中度、競争動向 ・DTC病気リスクおよび健康診断の世界市場規模 ・DTC病気リスクおよび健康診断の北米市場分析（アメリカ、カナダ、メキシコ等） ・DTC病気リスクおよび健康診断のアメリカ市場規模推移 ・DTC病気リスクおよび健康診断のカナダ市場規模推移 ・DTC病気リスクおよび健康診断のメキシコ市場規模推移 ・DTC病気リスクおよび健康診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The global Direct-to-consumer Disease Risk and Health Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019...
  • 病気リスクおよび健康DNA検査の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102764 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、病気リスクおよび健康DNA検査の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。病気リスクおよび健康DNA検査の世界市場概観、メーカー動向、メーカー別病気リスクおよび健康DNA検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・病気リスクおよび健康DNA検査の市場概観 ・病気リスクおよび健康DNA検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・病気リスクおよび健康DNA検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・病気リスクおよび健康DNA検査の世界市場規模 ・病気リスクおよび健康DNA検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・病気リスクおよび健康DNA検査のアメリカ市場規模推移 ・病気リスクおよび健康DNA検査のカナダ市場規模推移 ・病気リスクおよび健康DNA検査のメキシコ市場規模推移 ・病気リスクおよび健康DNA検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The worldwide market for Disease Risk and Health DNA Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019,...
  • 消費者への直接的な疾病リスクと健康DNA検査の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102767 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、消費者への直接的な疾病リスクと健康DNA検査の世界市場について調べ、まとめました。種類別セグメントは、I型、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。消費者への直接的な疾病リスクと健康DNA検査の世界市場概観、メーカー動向、メーカー別消費者への直接的な疾病リスクと健康DNA検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・消費者への直接的な疾病リスクと健康DNA検査の市場概観 ・消費者への直接的な疾病リスクと健康DNA検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・消費者への直接的な疾病リスクと健康DNA検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・消費者への直接的な疾病リスクと健康DNA検査の世界市場規模 ・消費者への直接的な疾病リスクと健康DNA検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・消費者への直接的な疾病リスクと健康DNA検査のアメリカ市場規模推移 ・消費者への直接的な疾病リスクと健康DNA検査のカナダ市場規模推移 ・消費者への直接的な疾病リスクと健康DNA検査のメキシコ市場規模推移 ・消費者への直接的な疾病リスクと健康DNA検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The worldwide market for Direct-to-consumer Disease Risk and Health DNA Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in...
  • DTC病気リスクおよび健康の遺伝学的検査の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102766 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、DTC病気リスクおよび健康の遺伝学的検査の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC病気リスクおよび健康の遺伝学的検査の世界市場概観、メーカー動向、メーカー別DTC病気リスクおよび健康の遺伝学的検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・DTC病気リスクおよび健康の遺伝学的検査の市場概観 ・DTC病気リスクおよび健康の遺伝学的検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・DTC病気リスクおよび健康の遺伝学的検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・DTC病気リスクおよび健康の遺伝学的検査の世界市場規模 ・DTC病気リスクおよび健康の遺伝学的検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・DTC病気リスクおよび健康の遺伝学的検査のアメリカ市場規模推移 ・DTC病気リスクおよび健康の遺伝学的検査のカナダ市場規模推移 ・DTC病気リスクおよび健康の遺伝学的検査のメキシコ市場規模推移 ・DTC病気リスクおよび健康の遺伝学的検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The worldwide market for Direct-to-consumer Disease Risk and Health Genetic Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in...
  • 鎌状赤血球症診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101229 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、鎌状赤血球症診断の世界市場について調べ、まとめました。種類別セグメントは、テストサービス、テストキット等、用途別セグメントは、新生児、大人等に区分しました。鎌状赤血球症診断の世界市場概観、企業動向、企業別鎌状赤血球症診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・鎌状赤血球症診断の市場概観 ・鎌状赤血球症診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・鎌状赤血球症診断の企業別販売動向、市場シェア、市場集中度、競争動向 ・鎌状赤血球症診断の世界市場規模 ・鎌状赤血球症診断の北米市場分析（アメリカ、カナダ、メキシコ等） ・鎌状赤血球症診断のアメリカ市場規模推移 ・鎌状赤血球症診断のカナダ市場規模推移 ・鎌状赤血球症診断のメキシコ市場規模推移 ・鎌状赤血球症診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Sickle Cell Disease Diagnosis market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sickle Cell Disease Diagnosis. Europe also play important...
  • オーエスキー病ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100289 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、オーエスキー病ワクチンの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥錠、注射剤等、用途別セグメントは、雌ブタ、子ブタ、イノシシ等に区分しました。オーエスキー病ワクチンの世界市場概観、メーカー動向、メーカー別オーエスキー病ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オーエスキー病ワクチンの市場概観 ・オーエスキー病ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オーエスキー病ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・オーエスキー病ワクチンの世界市場規模 ・オーエスキー病ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・オーエスキー病ワクチンのアメリカ市場規模推移 ・オーエスキー病ワクチンのカナダ市場規模推移 ・オーエスキー病ワクチンのメキシコ市場規模推移 ・オーエスキー病ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Aujeszky Disease Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Aujeszky Disease Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Zendal group(CZ Vaccines) Kyoritsuseiyaku Corporation Ceva IDEXX MSD Animal...

    • ◆H&Iグローバルリサーチのお客様（例）◆